4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride

We are 4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride CAS:437651-44-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride
CAS.NO: 437651-44-0
Benzoic acid, 4-[3-(dibutylamino)propoxy]-, hydrochloride (1:1)

Molecular Formula: C18H30ClNO3
Molecular Weight:343.88900

Physical and Chemical Properties:
Boiling point: 440.7ºC at 760 mmHg
Melting point: 155-157°C
Flash point:/
Refractive index:/

Appearance:Off-white to light yellow powder
Loss on drying:≤0.5%

 25kg  cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Dronedarone CAS:141626-36-0
Intermediates of Dronedarone hydrochloride CAS:141625-93-6

4-[3-(Dibutylamino)propoxy]benzoic acid hydrochloride

Related News: Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.530-62-1 It is delivered to hospitals and pharmacies until it reaches the patient.1-[2-(trifluoromethoxy)phenyl]ethanone CAS:220227-93-0 It is delivered to hospitals and pharmacies until it reaches the patient.methyl 2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetate CAS:258273-50-6 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.

Related Products
Product Name
7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid View Details
3-Amino-5-bromobenzotrifluoride View Details
5-Chloro-2,3-dibromopyridine View Details
2,5-Difluoroaniline manufacturer 2-Bromo-3-Fluoro-6-Picoline manufacturer N-Ac-D,L-Phg-OH manufacturer 4-AMINO-5-CHLORO-1,2,3-BENZOTHIADIAZOLE manufacturer 2,3,5,6-Tetrachloropyridine manufacturer